Eosinophilic Asthma
📧 Sign up to get email alerts when something new happens for Eosinophilic Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-13Clinical Trial Results: Severe Asthma, MepolizumaB and Affect: SAMBA Study
Clinical trial results for SAMBA study evaluating Mepolizumab in severe eosinophilic asthma with psychological distress were completed and r…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: STEP: Phase IIIb Study of Benralizumab to Step-down Maintenance Therapy in Patients With Severe Eosinophilic Asthma [Phase 3]
Phase IIIb trial update for benralizumab as step-down maintenance therapy in severe eosinophilic asthma; the study is currently active but n…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Mepolizumab Effectiveness in Patients With Chronic Rhinosinusitis, Nasal Polyps and Comorbid Severe Eosinophilic Asthma
A clinical trial update assessing the effectiveness of mepolizumab for patients with chronic rhinosinusitis with nasal polyps and comorbid s…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: A Real World Study to Capture Clinical and Patient Centered Outcomes in Adults With Severe Eosinophilic Asthma Treated With Benralizumab.
Real-world study results in adults with severe eosinophilic asthma treated with benralizumab (Fasenra) has been completed, focusing on clini…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Changes in Gene Transcription and Immunophenotypes Following Mepolizumab Treatment for Asthma
This Mayo Clinic-sponsored clinical trial in eosinophilic asthma assessed mepolizumab and reports changes in gene transcription and immunoph…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Patient-Reported OUTcomes of Benralizumab in Real-World Use in Severe EosiNophilic Asthma Patients
This completed clinical trial update reports patient-reported outcomes for benralizumab used in real-world treatment of severe eosinophilic …
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Efficacy of Mepolizumab in Polish Patients With Severe Eosinophilic Asthma
A clinical trial update reports the efficacy of mepolizumab in Polish patients with severe eosinophilic asthma, with results posted on Clini…
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: Phase III Long-Term Extension Study With Dexpramipexole [Phase 3]
Areteia Therapeutics reports termination of the Phase III long-term extension study of dexpramipexole for eosinophilic asthma. The trial sta…
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: REverse LuNg Airway and Vascular RemOdeling in Asthma ReMission (ReNORM) [NA]
Clinical trial REverse Lung Airway and Vascular Remodeling in Asthma Remission (ReNORM) is not yet recruiting and is studying asthma with eo…
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: AD17002 Treating Poorly Controlled, Moderate to Severe Eosinophilic Asthma [Phase 1, Phase 2]
Clinical trial AD17002 for poorly controlled, moderate-to-severe eosinophilic asthma has completed Phase 1 and Phase 2 studies.
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma [Phase 3]
Phase 3 clinical trial update for dexpramipexole in adolescents and adults with eosinophilic asthma; the study is listed as active but not r…
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Identification of Autoantigens in EGPA and Severe Eosinophilic Asthma
A completed study from Queen Mary University of London investigates autoantigens in eosinophilic granulomatosis with polyangiitis (Churg-Str…
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: A Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With Benralizumab [Phase 4]
Phase 4 trial update evaluating whether reducing daily ICS/LABA maintenance to an anti-inflammatory reliever approach is feasible in severe …
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Real World Evidence of Benralizumab in Eosinophilic Severe AsThma in Russia (BEST)
This is a real-world evidence update on benralizumab for severe eosinophilic asthma in Russia (BEST), based on a completed study.
-
CLINICAL_TRIALS trial_result · 2024-07-01Clinical Trial Update: Patient Reported Outcomes in Adults With Severe Eosinophilic Asthma on Benralizumab.
This clinical trial update reports patient-reported outcomes from a completed study of benralizumab in adults with severe eosinophilic asthm…
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: Asthma Control in a Dutch Primary Care Population
Completed clinical trial evaluating asthma control in a Dutch primary care population. The provided snippet does not include results.
-
CLINICAL_TRIALS trial_result · 2024-03-04Clinical Trial Update: BenRalizumab Effect on Airway Remodeling in Severe asTHma [Phase 4]
Phase 4 clinical trial evaluating benralizumab's effect on airway remodeling in severe asthma with eosinophilic features; recruiting.
-
CLINICAL_TRIALS trial_result · 2024-01-25Clinical Trial Update: Efficacy of Reslizumab Dose Escalation in Patients With Severe Asthma [Phase 4]
Phase 4 trial evaluating dose escalation of reslizumab in patients with severe eosinophilic asthma.
-
CLINICAL_TRIALS trial_result · 2023-08-16Clinical Trial Update: Proof of Concept Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Severe Eosinophilic Asthma [Phase 2]
A Phase 2 proof-of-concept study evaluating Etokimab (ANB020) in adults with severe eosinophilic asthma has completed, with results posted i…
-
CLINICAL_TRIALS trial_result · 2023-05-18Clinical Trial Update: PK/PD and Long Term Safety Study of Benralizumab in Children With Severe Eosinophilic Asthma [Phase 3]
Phase 3 trial update assessing benralizumab in children with severe eosinophilic asthma, focusing on PK/PD and long-term safety.
-
CLINICAL_TRIALS trial_result · 2022-04-08Clinical Trial Update: Efficacy and Safety of CHF 6532 in Patients With Uncontrolled Severe Eosinophilic Asthma [Phase 3]
Phase 3 trial update for CHF 6532 in uncontrolled severe eosinophilic asthma; study terminated.
-
CLINICAL_TRIALS trial_result · 2021-12-22Clinical Trial Update: Dexpramipexole Dose-Ranging Biomarker Study in Subjects With Eosinophilic Asthma [Phase 2]
Phase 2 dose-ranging biomarker study of dexpramipexole in eosinophilic asthma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-14Clinical Trial Update: Comparing Treatment Efficacy With Mepolizumab and Omalizumab in Severe Asthma - "Choosebetweenamab". [Phase 4]
Phase 4 trial comparing efficacy of Mepolizumab versus Omalizumab in severe asthma (Choosebetweenamab). Status is unknown.
-
CLINICAL_TRIALS trial_result · 2020-01-14Clinical Trial Update: A Pragmatic Study to Investigate the Efficacy and Safety of Mepolizumab in Severe Uncontrolled Asthma in Brazil [Phase 4]
A Phase 4 pragmatic study evaluating the efficacy and safety of mepolizumab for severe uncontrolled asthma in Brazil.
-
CLINICAL_TRIALS trial_result · 2019-08-29Clinical Trial Update: Effect of OC000459 on Eosinophilic Airway Inflammation in Severe Asthma [Phase 2]
Phase 2 trial update on OC000459 for eosinophilic airway inflammation in severe asthma has completed.